The research on CHMP2B is mainly focused on autophagy, frontotemporal dementia and amyotrophic lateral sclerosis36–38, suggesting that CHMP2B could be one of the targets through which CCT2 participated in autophagy and affecting the course of AMD. Here, CHMP2B is linked to frontotemporal dementia.